AstraZeneca (AZN)
Create an Alert
50.87
-0.11 -0.22%
NYSE
Jun 19, 12:58PM
BATS Real time
Currency in USD
AstraZeneca Free Cash Flow:
1.784B for March 31, 2013AstraZeneca Historical Free Cash Flow Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 1.784B |
| Dec. 31, 2012 | 2.284B |
| Sept. 30, 2012 | -2.263B |
| June 30, 2012 | 970.00M |
| March 31, 2012 | 1.338B |
| Dec. 31, 2011 | 2.691B |
| Sept. 30, 2011 | 1.679B |
| June 30, 2011 | 535.00M |
| March 31, 2011 | 1.619B |
| Dec. 31, 2010 | 3.093B |
| Sept. 30, 2010 | 2.124B |
| June 30, 2010 | 2.546B |
| March 31, 2010 | 736.00M |
| Dec. 31, 2009 | 3.496B |
| Sept. 30, 2009 | 1.867B |
| June 30, 2009 | 2.847B |
| March 31, 2009 | 1.943B |
| Dec. 31, 2008 | 2.298B |
| Sept. 30, 2008 | 1.39B |
| June 30, 2008 | 1.562B |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Free Cash Flow
Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.
According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More
AZN Free Cash Flow Benchmarks
| Companies | |
|---|---|
| GlaxoSmithKline | 1.413B |
| Pfizer | 2.039B |
| Merck | 1.99B |
AZN Free Cash Flow Rankings
| Overall |
99th percentile 65 of 16782 |
| Sector |
99th percentile 4 of 1410 in Healthcare |
| Industry |
97th percentile 3 of 135 in Drug Manufacturers - Major |
AZN Free Cash Flow Range, Past 5 Years
| Minimum | -2.263B | Sep 2012 |
| Maximum | 3.496B | Dec 2009 |
| Average | 1.727B |
